LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: A comparison with the antidepressant, nefazodone

European Journal of Pharmacology

Volumn 407, Issue 1-2, 2000, Pages 39-46

  Pullar, Ian A ^a   Carney, Stephen L ^a   Colvin, Ellen M ^a   Lucaites, Virginia L ^a   Nelson, David L ^a   Wedley, Susan ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT transporter; 5 HT(2A) receptor; Nefazodone

Indexed keywords

AMESERGIDE; ANTIDEPRESSANT AGENT; CLOZAPINE; FLUOXETINE; IMIPRAMINE; INDALPINE; KETANSERIN; LY 367265; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 3 METHYL 4 (4 PYRIDYL)BENZAMIDE; NEFAZODONE; PAROXETINE; RITANSERIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SYNAPTOSOME;

ANIMAL; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARRIER PROTEINS; CEREBRAL CORTEX; CYCLIC S-OXIDES; GUINEA PIGS; HUMAN; MALE; MEMBRANE GLYCOPROTEINS; NOREPINEPHRINE; RATS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SYNAPTOSOMES; THIADIAZOLES; TRIAZOLES;

EID: 0034721994     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00728-7     Document Type: Article

References (42)

1. 18F]-setoperone during depressive illness and antidepressant traetment with clomipramine
2. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression
3. Effect of ritanserin on sleep stages and sleep EEG in the rat
4. Sexual functioning in depressed patients taking mirtazapine
5. Evidence for presynaptic location of inhibitory 5-HT(1Dβ)-like autoreceptors in the guinea-pig brain cortex
6. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain
7. 50) of an enzymatic reaction
8. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344964, a selective serotonin(1F) receptor agonist in rabbit saphonous vein
9. Nefazodone: a review of its pharmacology and clinical efficacy in the management of depression
10. 5HT2 receptors, depression and anxiety
11. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra
12. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat
13. Nefazodone: preclinical pharmacology of a new antidepressant
14. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability and effects on sexual function and satisfaction
15. A double-blind comparison of nefazodone, imipramine and placebo in major depression
16. Preclinical studies on LY237733, a potent and selective serotonergic antagonist
17. ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, γ-aminobutyric acid and glutamate from rat brain slices
18. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala
19. 2 receptors
20. 5-hydroxytryptamine-2 antagonist increases human slow wave sleep
21. Clozapine acts as a 5-HT2 antagonist by attenuating DOI-induced inhibition of male rat sexual behaviour
22. The use of mertazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction
23. Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra
24. Protein measurement with the folin phenol reagent
25. 2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment
26. Pharmacological diversity between native human 5-HT(1B) and 5-HT(1D) receptors sited on different neurons and involved in different functions
27. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach towards efficient antidepressants
28. 18F]setoperone PET imaging study
29. SB-236057, a selective 5-HT(1B) receptor inverse agonist, blocks the 5-HT human terminal autoreceptor
30. Selective serotonin reuptake inhibitors in the acute treatment of depression
31. Novel pharmacological approaches to the treatment of depression
32. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
33. Nefazodone and imipramine in major depression: a placebo-controlled trial
34. Combining administration of a 5-hydroxytryptamine (5-HT)(1D) antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo
35. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
36. Serotonin 5-HT2 receptor antagonists: potential in the treatment of psychiatric disorders
37. Treatment resistant depression
38. Nefazodone and depression
39. Pharmacologic characterisation of the human 5-hydroxytryptamine(2B) receptors: evidence for species differences
40. 2 antagonists
41. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors
42. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone